DR-TB STAT

New guide: Your rights and TB care

An innovative and important new TB resource – Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment Guide.

Read More →

Webinar: The results are in! Now what? - webinar materials now available online

The first ever phase III trials for multidrug-resistant TB (MDR-TB) finally yielded results. Treatment Action Group (TAG), ACTION, and the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) presented the results in a webinar held on 12 December 2017. The webinar explored implications for the field, from the delamanid C213 trial and the STREAM trial to evaluate the shorter regimen for MDR-TB.

Read More →

Webinar: The results are in! Now what?

Exploring the implications of the delamanid phase III and STREAM trial results

Read More →

Phase III clinical trial results at the 48th Union World Conference on Lung Health: Implications for the field

Preliminary results from two phase III drug-resistant TB (DR-TB) clinical trials were presented at the 48th Union World Conference on Lung Health: stage 1 of the STREAM trial and the Otsuka 213 delamanid trial.

Read More →

Webinar on MDR-TB treatment with bedaquiline in children and adolescents: experience from Belarus

DR-TB STAT and the Sentinel Project will host a webinar, MDR-TB Treatment with Bedaquiline in Children and Adolescents: Global Recommendations and Program Experience in Belarus on 21 November 2017.

Read More →

Webinar on MDR-TB treatment with bedaquiline in children and adolescents: experience from Belarus

DR-TB STAT and the Sentinel Project will host a webinar, MDR-TB Treatment with Bedaquiline in Children and Adolescents: Global Recommendations and Program Experience in Belarus on 26 May 2017.

Read More →

Webinar on treating children with MDR-TB without an injectable

DR-TB STAT and the Sentinel Project will host a webinar on 7 April 2017, The Time Has Come: The Case for Injectable-Sparing Treatment Regimens for Children with MDR-TB.

Read More →

DR-TB STAT on WHO bedaquiline recommendations

The DR-TB Scale-Up Treatment Action Team (DR-TB STAT) issued a Bedaquiline Bulletin.

Read More →

DR-TB STAT: September 2016 summary and updates

The DR-TB Scale-Up Treatment Action Team (DR-TB STAT) released its September 2016 update informing about the general progress in the introduction of bedaquiline and delamanid in TB programs worldwide.

Read More →

Call to Action to accelerate access to DR-TB drugs: 2016 update

The update informs about the general progress in the introduction of bedaquiline and delamanid in TB programs worldwide and reports on the requests made in the Call to Action issued in March 2015.

Read More →

Page 1 of 1 · Total posts: 10

1